Cardiovascular Safety of Xenon in General Anaesthesia, in Patient With Cardiovascular Risk in Non Cardiac Surgery
Status:
Completed
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
The Primary Objective is to show non inferiority in cardiac safety (i.e myocardial
necrosis-MN- assessed by positive cardiac Troponin I -cTnI- ultrasensitive assay) of a Xenon
based general anesthesia procedure in patients with elevated cardiac risk scheduled for
atherosclerotic vascular surgery (i.e patient with Coronary Arteries Disease risk) when
compared to sevoflurane based general anesthesia procedure, postoperatively up to 3 days.